Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Sales (2016 - 2025)

Historic Return on Sales for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.5%.

  • Fortress Biotech's Return on Sales rose 23300.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.21%, marking a year-over-year increase of 6900.0%. This contributed to the annual value of 2.1% for FY2024, which is 2700.0% down from last year.
  • Latest data reveals that Fortress Biotech reported Return on Sales of 0.5% as of Q3 2025, which was up 23300.0% from 2.18% recorded in Q2 2025.
  • Fortress Biotech's 5-year Return on Sales high stood at 0.5% for Q3 2025, and its period low was 4.65% during Q1 2023.
  • Over the past 5 years, Fortress Biotech's median Return on Sales value was 2.38% (recorded in 2021), while the average stood at 2.26%.
  • Examining YoY changes over the last 5 years, Fortress Biotech's Return on Sales showed a top increase of 29000bps in 2023 and a maximum decrease of -26800bps in 2023.
  • Quarter analysis of 5 years shows Fortress Biotech's Return on Sales stood at 3.41% in 2021, then decreased by -3bps to 3.5% in 2022, then surged by 59bps to 1.45% in 2023, then dropped by -20bps to 1.74% in 2024, then soared by 129bps to 0.5% in 2025.
  • Its Return on Sales was 0.5% in Q3 2025, compared to 2.18% in Q2 2025 and 1.66% in Q1 2025.